Medical Devices Startups

KORSUVA is a prescription medicine that treats moderate-to-severe itching associated with chronic kidney disease in adults undergoing hemodialysis. The product is marketed by Vifor (International) Inc.

1 investor

KuartisMED develops AI-enabled solutions for newborn health monitoring and clinical decision support, particularly for premature babies. The platform is designed to assist physicians with clinical insights and provide information to parents.

1 investor

Kuros Biosciences is a Swiss biotech company developing biologic technologies for bone healing and bone grafts, primarily for spine, extremities, and pelvis surgical applications. Originally a spin-off of the Swiss Federal Institute of Technology in Zurich, it is publicly listed on the SIX Swiss Stock Exchange and operates in Switzerland, the Netherlands, and the USA.

1 investor

Kyo provides Applied Behavior Analysis (ABA) therapy for children with autism and their families, delivering treatment in home and school settings with a focus on measurable outcomes. The company uses a mobile app to coordinate care between families and therapy teams.

1 investor

Labops develops AI infrastructure for healthcare, including foundation models and clinical software designed specifically for medical reasoning and life sciences applications. The company creates trusted AI systems that enable organizations to build and deploy reliable healthcare AI tools.

1 investor

Laborie develops medical devices and solutions for women's health, including technologies to manage complications like postpartum hemorrhage.

1 investor

Lab Quality provides external quality assessment (EQA) programs for medical laboratories and point-of-care testing sites, offering over 250 clinically relevant quality assessment schemes compliant with ISO 15189 standards.

1 investor

Ladder Bio (formerly ThirdLaw Molecular) develops Spiroligomer molecules, a class of synthetic, modular fused-ring compounds designed for highly selective binding to target proteins, along with computational design tools for targeted drug discovery. The platform is aimed at creating therapeutics and diagnostic tests as synthetic alternatives to peptides and antibodies.

1 investor

LAM-X develops nanofiber materials using patented light-activated photosensitizer technology that generates reactive oxygen species to kill microorganisms, applied to antimicrobial textiles and medical devices such as intravenous catheter dressings. It also produces life science products including a biodegradable universal Western Blot membrane (VerdiBlot) for protein analysis, with applications spanning medical devices, food packaging, crop protection, and water filtration.

1 investor

Lamina Therapeutics develops Lamina.One, a combined advanced therapy medicinal product for bone and cartilage regeneration that pairs a biodegradable polymeric membrane with hydroxyapatite and an autologous mesenchymal stem cell hydrogel to treat knee osteoarthritis and orthopaedic, maxillofacial, and periodontal conditions. A spin-off from INSERM and the University of Strasbourg's Regenerative Nanomedicine unit, it has EMA and ANSM authorization for a Phase I clinical trial in Strasbourg, France.

1 investor

Lantheus is a radiopharmaceutical company that develops, manufactures, and commercializes radiodiagnostics and radiotherapeutics for cancer detection, treatment and monitoring, as well as precision diagnostics for non-oncologic diseases.

1 investor

LaNua Medical is a medtech company developing image-guided endovascular devices for embolization, a minimally invasive procedure used to treat internal bleeding and tumors. Its ECORE device blocks blood flow to targeted tissue while enabling distal therapeutic delivery, aimed at interventionalists treating vascular diseases and cancers.

1 investor

Laronix develops a portable voicing device for individuals experiencing voice loss across multiple diagnoses, enabling communication in various contexts without surgical intervention.

1 investor

LarynxLock is a single-use medical device that prevents airway leakage in supraglottal airway devices, applied externally to patient skin for use in operating rooms, pre-hospital settings, and procedural sedation. The device is made with biodegradable, eco-friendly materials and requires no advanced training to apply.

1 investor

Latica-Med develops acoustic pulse technology to treat female reproductive disorders and improve fertility outcomes in IVF procedures by addressing endometrial thickness, infections, and implantation failures through non-invasive, non-drug therapy.

1 investor

Lattice provides monitoring and compliance oversight for clinical AI models running in hospitals. The platform detects model drift, fairness issues, and silent updates across multiple vendor AI systems, delivering cryptographically signed daily reports to hospital leadership without requiring access to patient data.

1 investor

LatticeX (formerly ACME Advanced Materials) develops microsystem devices and microfabrication processes for medical, industrial, defense, and aerospace applications. The company leverages partnerships with leading industrial corporations to commercialize advanced technology solutions.

1 investor

Lattice MedTech operates a medical device distribution and manufacturing platform in India, serving global brands and Indian manufacturers across specialties such as cardiology, orthopedics, general surgery, critical care, and IVD. It provides pan-India fulfillment, warehousing, and cold-chain infrastructure to deliver devices to hospitals, clinics, and tier-2/3 cities.</parameter> <parameter name="hq_country">IN

1 investor

Lauxera is an independent investment fund that backs growth-stage healthtech companies with significant revenue and commercial execution capabilities. The firm provides business development support, talent management expertise, and growth guidance to portfolio companies across Europe and internationally.

1 investor

Leal Therapeutics is a company focused on CNS (central nervous system) disorders, drawing on academic and drug-development experience in neurology and neurodegenerative disease.

1 investor

Leapfrog Bio is an oncology therapeutics company that uses its Precision PGx Platform to identify and develop targeted cancer treatments, focusing on patients with loss-of-function mutations through synthetic lethality and pharmacogenomic screening.

1 investor

Leap Therapeutics develops targeted and immunotherapy-based cancer treatments, including monoclonal antibodies in clinical development for esophagogastric, gynecologic, colorectal, gastric, and pancreatic cancers.

1 investor

LEFMEDPACKS operates a purpose-built plant that produces sterilizable medical flexible packaging, using coating, printing and slitting equipment in a controlled clean production environment. It serves the medical industry worldwide through a dedicated sales team and a network of local conversion partners.

1 investor

Legent Health operates healthcare facilities and clinical services, with regional operations in Texas and Florida. The company's leadership spans clinical operations, managed care contracting, and business development.

1 investor